SCHEMBL7991807

SCHEMBL7991807

O=C(O)C(=O)Nc1cnccc1C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 19/20 0.64
KDM4D Q6B0I6 6/20 0.64
KDM6B O15054 9/20 0.59
EGLN3 Q9H6Z9 1/20 0.56
KDM5A P29375 1/20 0.55
KDM5B Q9UGL1 1/20 0.55
KDM4E B2RXH2 2/20 0.54
KDM4A O75164 2/20 0.54
PTPN1 P18031 1/20 0.51
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
THRB P10828 1/20 0.50
KMT2A Q03164 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4934772 0.86 IRAK4 (0.49) KDM4CKDM4DKDM6BEGLN3KDM5A
SCHEMBL4439968 0.82 KDM4C (0.69) KDM4CKDM4DKDM6BEGLN3KDM5A
SCHEMBL20982055 0.79 KDM4C (0.70) KDM4CKDM4DKDM6BEGLN3KDM5B
SCHEMBL4932602 0.79 KDM4C (0.56) KDM4CKDM4DKDM6BEGLN3KDM5A
SCHEMBL13789509 0.78 KDM4C (0.67) KDM4CKDM4DKDM6BEGLN3KDM5A
SCHEMBL15295159 0.78 KDM4C (1.00) KDM4CKDM4DKDM6BEGLN3KDM5A
SCHEMBL12830011 0.78 KDM4C (0.68) KDM4CKDM4DKDM6BEGLN3KDM5B
SCHEMBL31574278 0.78 KDM4C (1.00) KDM4CKDM4DKDM6BEGLN3KDM5A
SCHEMBL16703135 0.77 KDM4C (0.58) KDM4CKDM4DKDM6BEGLN3KDM5A
SCHEMBL23796861 0.76 KDM4C (0.64) KDM4CKDM4DKDM6BEGLN3KDM5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1062199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP claimed
WO-1999046236-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO claimed
US-6225329-B1 USEFUL IN THE TREATMENT OF TYPE I DIABETES, TYPE II DIABETES, IMPAIRED GLUCOSE TOLERANCE, INSULIN AUTOIMMUNITY DISEASES WITH DYSFUNCTIONS OF THE COAGULATION SYSTEM, ALLERGIC DISEASES NOVO NORDISK A/S (DK) 2001-05-01 US disclosed
EP-1062199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP disclosed
WO-1999046236-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed